Discontinued in 2017. The primary mission of Translational OncoGenomics is to provide an open-access, peer-reviewed, rapid-publication forum to assist in the dissemination of novel genetic, epigenetic and molecular pathway information related to clinical cancer. The journal is designed to meet the scientific and public need for such a forum in order to process the accelerating acquisition of genomic data resultant from recent technological advances in and international programmatic commitments to this area of research. Particularly encouraged is the submission of papers with a translational connection to human cancer from basic science to ethical considerations related to the application of oncogenomic discoveries for diagnostic and prognostic purposes in clinical trials and for anti-cancer drug development. An important objective will be to contribute information published in this forum to comprehensive internationally-accessible genomic databases in order to foster the identification of molecular targets for the therapy of specific cancers.
- Further information
- Category Links